RichardLDemingMD

Clinical Trials

• Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System Start of enrollment: 2004 Jan 01

  Terminated

  Phase 2

• Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum Start of enrollment: 2004 Dec 01

  Terminated

  Phase 2

• Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2006 Jul 01

  Completed

  Phase 3

• Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Start of enrollment: 2011 Jan 24

  Active, not recruiting

  Phase 3

• Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors Start of enrollment: 2018 Oct 26

  Active, not recruiting

  Phase 3

• Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations Start of enrollment: 2018 Aug 01

  Recruiting

  Phase 2

• Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2019 Jul 25

  Active, not recruiting

  Phase 2

• Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers Start of enrollment: 2019 Feb 07

  Active, not recruiting

  Phase 3

• Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) Start of enrollment: 2019 Jul 26

  Active, not recruiting

  Phase 3

• Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer Start of enrollment: 2019 May 14

  Active, not recruiting

• Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer Start of enrollment: 2019 Jul 19

  Active, not recruiting

• Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer Start of enrollment: 2020 Jun 17

  Recruiting

  Phase 2, Phase 3

• Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer Start of enrollment: 2020 Aug 13

  Recruiting

  Phase 3

• Serum-derived Bovine Immunoglobulin Effect on Mucositis Start of enrollment: 2020 Jan 17

  Terminated

  Phase 2

• Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker Start of enrollment: 2020 Jul 20

  Active, not recruiting

  Phase 2

• Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer Start of enrollment: 2020 Dec 09

  Terminated

  Phase 3

• Join now to see all